Abbvie Inc.

Chih-Wei Lin

Sandeep Dutta

Walid M Awni

Barry M Bernstein

Sven Mensing

Rajeev M Menon

Thomas J Podsadecki

Wei Liu

Andrew L Campbell

Tianli Wang

The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.

Methods for treating HCV

Method for treating HCV

Growing community of inventors

Vernon Hills, IL, United States of America

Chih-Wei Lin